×
Entrez Id:
2153
Gene Symbol:
F5
F5
0.500
Biomarker
phenotype
CTD_human
DVT: Factor V Leiden, a case report.
12827938
2003
×
Entrez Id:
2153
Gene Symbol:
F5
F5
0.500
Biomarker
phenotype
CTD_human
[Pulmonary arterial thromboembolism and thrombophilias: optimization of diagnostics and treatment].
16875063
2006
×
Entrez Id:
2153
Gene Symbol:
F5
F5
0.500
GeneticVariation
phenotype
LHGDN
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
15077257
2004
×
Entrez Id:
2153
Gene Symbol:
F5
F5
0.500
GeneticVariation
phenotype
LHGDN
Factor V Leiden , prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
18160601
2008
×
Entrez Id:
2153
Gene Symbol:
F5
F5
0.500
GeneticVariation
phenotype
GWASDB
Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis.
22675575
2012
×
Entrez Id:
2153
Gene Symbol:
F5
F5
0.500
Biomarker
phenotype
CTD_human
Detection of factor V leiden and prothrombin gene mutations in patients who died with thrombotic events.
12296757
2002
×
Entrez Id:
2153
Gene Symbol:
F5
F5
0.500
GeneticVariation
phenotype
LHGDN
Mechanisms of the factor V Leiden paradox.
18617648
2008
×
Entrez Id:
2153
Gene Symbol:
F5
F5
0.500
Biomarker
phenotype
CTD_human
Recurrent episodes of deep vein thrombosis in a young man.
12865888
2003
×
Entrez Id:
2153
Gene Symbol:
F5
F5
0.500
GeneticVariation
phenotype
LHGDN
Arterial thrombosis associated with factor V Leiden and methylenetetrahydrofolate reductase C677T mutation in childhood membranous glomerulonephritis.
18030499
2008
×
Entrez Id:
2153
Gene Symbol:
F5
F5
0.500
Biomarker
phenotype
LHGDN
A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
17555744
2007
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
0.460
Biomarker
phenotype
HPO
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
0.460
GeneticVariation
phenotype
LHGDN
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms.
19105231
2009
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
0.460
Biomarker
phenotype
CTD_human
JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders.
20434300
2010
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
0.460
GeneticVariation
phenotype
LHGDN
A substantial proportion of patients with splanchnic venous thrombosis and a small, but significant, number of patients with CVT can be recognized as carriers of the JAK2 V617F mutation in the absence of overt signs of CMD.
17263783
2007
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
0.460
GeneticVariation
phenotype
LHGDN
The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder.
18521518
2008
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
0.460
GeneticVariation
phenotype
LHGDN
JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients.
18380991
2008
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
0.460
GeneticVariation
phenotype
LHGDN
Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation.
18327418
2008
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
0.460
GeneticVariation
phenotype
LHGDN
JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder.
17460706
2007
×
Entrez Id:
5624
Gene Symbol:
PROC
PROC
0.430
Biomarker
phenotype
CTD_human
Compound heterozygous protein C deficiency in a family with venous thrombosis: Identification and in vitro study of p.Asp297His and p.Val420Leu mutations.
25748729
2015
×
Entrez Id:
5624
Gene Symbol:
PROC
PROC
0.430
Biomarker
phenotype
CTD_human
The increase in resistance to APC was not explained by changes in protein S, protein C, or prothrombin and may contribute to the increased incidence of venous thrombosis in users of hormone replacement therapy.
12730085
2003
×
Entrez Id:
5624
Gene Symbol:
PROC
PROC
0.430
Biomarker
phenotype
LHGDN
Four cases of venous thrombosis in athletes with silent hereditary defects of the protein C system.
16113841
2005
×
Entrez Id:
5624
Gene Symbol:
PROC
PROC
0.430
Biomarker
phenotype
HPO
×
Entrez Id:
5624
Gene Symbol:
PROC
PROC
0.430
GeneticVariation
phenotype
LHGDN
Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
18160601
2008
×
Entrez Id:
5624
Gene Symbol:
PROC
PROC
0.430
Biomarker
phenotype
LHGDN
Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
15860736
2005
×
Entrez Id:
93183
Gene Symbol:
PIGM
PIGM
0.400
Biomarker
phenotype
CTD_human
Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency.
16767100
2006